|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.645 USD | -0.30% |
|
-18.56% | -88.41% |
| 06-02 | NextCure, Inc. - Special Call | |
| 06-01 | NextCure, Inc. Presents Positive SIM0505 Phase 1 Dose Escalation Data In Patients With Gynecologic Cancers At ASCO | CI |
| Market Cap | 5.94M 5.21M 4.8M 4.5M 8.43M 561M 8.61M 57.72M 22.33M 277M 22.31M 21.82M 961M | P/E 2026 * |
-0.22x | P/E 2027 * | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 5.94M 5.21M 4.8M 4.5M 8.43M 561M 8.61M 57.72M 22.33M 277M 22.31M 21.82M 961M | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.2% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: NextCure, Inc.
| 1 day | -0.30% | ||
| 1 week | -18.56% | ||
| Current month | -73.47% | ||
| 1 month | -76.57% | ||
| 3 months | -83.76% | ||
| 6 months | -87.12% | ||
| Current year | -88.41% |
| 1 week | 1.55 |  | 2.11 |
| 1 month | 1.55 | | 6.96 |
| Current year | 1.55 | | 14.65 |
| 1 year | 1.55 | | 15.74 |
| 3 years | 1.55 | | 30.84 |
| 5 years | 1.55 | | 110.16 |
| 10 years | 1.55 | | 1,308 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Richman
CEO | Chief Executive Officer | 65 | 30/11/2015 |
Steven Cobourn
DFI | Director of Finance/CFO | 63 | 31/12/2017 |
Udayan Guha
CTO | Chief Tech/Sci/R&D Officer | 54 | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Richman
BRD | Director/Board Member | 65 | 30/11/2015 |
Elaine Jones
BRD | Director/Board Member | 71 | 30/11/2015 |
David Kabakoff
CHM | Chairman | 78 | 30/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-17 | Free | Director | 2,340 | 0.0874% | ||
| 06-17 | Free | Director | 2,340 | 0.0874% | ||
| 06-17 | Free | Director | 2,340 | 0.0874% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.30% | -18.56% | -70.20% | -91.16% | 5.94M | |
| +0.33% | +1.37% | +64.03% | +119.11% | 55.63B | |
| +0.82% | +15.05% | +79.93% | +84.34% | 52.25B | |
| +1.36% | +0.36% | -14.06% | -14.69% | 23.07B | |
| -1.04% | +7.91% | +1.61% | +419.24% | 22.41B | |
| -0.18% | +7.20% | +32.16% | -14.07% | 17.32B | |
| -1.10% | +4.00% | +28.70% | -34.51% | 15.94B | |
| -3.35% | +8.96% | +132.20% | +290.18% | 13.47B | |
| +2.89% | +5.51% | +27.11% | +181.45% | 13.77B | |
| +1.31% | +0.53% | +28.62% | - | 12.43B | |
| Average | +0.07% | +2.44% | +31.01% | +104.43% | 22.63B | |
| Weighted average by Cap. | +0.26% | +5.13% | +48.49% | +120.17% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | -41.32M -36.23M -33.39M -31.26M -58.62M -3.9B -59.84M -401M -155M -1.93B -155M -152M -6.68B | -55.23M -48.43M -44.64M -41.79M -78.37M -5.21B -79.99M -537M -208M -2.58B -207M -203M -8.93B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26/06/26 | US$1.645 | -0.30% | 64,506 |
| 25/06/26 | US$1.650 | -6.78% | 88,961 |
| 24/06/26 | US$1.770 | -2.21% | 120,330 |
| 23/06/26 | US$1.810 | +3.43% | 163,687 |
| 22/06/26 | US$1.750 | -13.37% | 175,408 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NXTC Stock
Select your edition
All financial news and data tailored to specific country editions
